Another setback in the industry's push to develop a disease-modifying therapy for the treatment of Alzheimer's disease.
Latest Video
New Stories
-
Arthritis Australia appoints Louise Hardy as CEO at pivotal moment for national advocacy
February 2, 2026 - - Latest News -
AusBiotech urges adoption of national life sciences strategy as global competition intensifies
February 2, 2026 - - Australian Biotech -
Cyclopharm delivers record revenue as US emerges as growth engine
February 2, 2026 - - Australian Biotech -
Sandoz adds to vision care options with the listing of biosimilar
February 2, 2026 - - Latest News -
PYC’s capital raise marks one of the largest biotech fundraisings in Australian market history
February 2, 2026 - - Australian Biotech -
Genetic Signatures appoints seasoned life sciences executive as CEO
February 2, 2026 - - Australian Biotech -
EMA decision clears regulatory path for Argenica’s lead stroke drug in Europe
February 2, 2026 - - Australian Biotech

